COVID-19 Impact on Global Nuclear Medicine/Radiopharmaceutic, Market Insights and Forecast to 2026
Nuclear Medicine/Radiopharmaceutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Medicine/Radiopharmaceutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Nuclear Medicine/Radiopharmaceutic market is segmented into
The Nuclear Medicine/Radiopharmaceutic market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nuclear Medicine/Radiopharmaceutic market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nuclear Medicine/Radiopharmaceutic Market Share Analysis
Nuclear Medicine/Radiopharmaceutic market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nuclear Medicine/Radiopharmaceutic business, the date to enter into the Nuclear Medicine/Radiopharmaceutic market, Nuclear Medicine/Radiopharmaceutic product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Nuclear Medicine/Radiopharmaceutic market is segmented into
- Tc-99
- I-123/131
- In-111
- Xe-133
- Th-201
- Ga-67
- Other
- Diagnostic
- Therapeutic
The Nuclear Medicine/Radiopharmaceutic market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nuclear Medicine/Radiopharmaceutic market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nuclear Medicine/Radiopharmaceutic Market Share Analysis
Nuclear Medicine/Radiopharmaceutic market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nuclear Medicine/Radiopharmaceutic business, the date to enter into the Nuclear Medicine/Radiopharmaceutic market, Nuclear Medicine/Radiopharmaceutic product introduction, recent developments, etc.
The major vendors covered:
- GE Healthcare
- Bracco Imaging
- Mallinckrodt
- Lantheus Medical Imaging
- Bayer
- Jubilant Pharma
- Nordion
- Eli Lilly
- SIEMENS
- China Isotope & Radiation
- Yantai Dongcheng Biochemicals
1 STUDY COVERAGE
1.1 Nuclear Medicine/Radiopharmaceutic Product Introduction
1.2 Market Segments
1.3 Key Nuclear Medicine/Radiopharmaceutic Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Type
1.4.2 Tc-99
1.4.3 I-123/131
1.4.4 In-111
1.4.5 Xe-133
1.4.6 Th-201
1.4.7 Ga-67
1.4.8 Other
1.5 Market by Application
1.5.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Application
1.5.2 Diagnostic
1.5.3 Therapeutic
1.6 Coronavirus Disease 2019 (Covid-19): Nuclear Medicine/Radiopharmaceutic Industry Impact
1.6.1 How the Covid-19 is Affecting the Nuclear Medicine/Radiopharmaceutic Industry
1.6.1.1 Nuclear Medicine/Radiopharmaceutic Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Nuclear Medicine/Radiopharmaceutic Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Nuclear Medicine/Radiopharmaceutic Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Estimates and Forecasts
2.1.1 Global Nuclear Medicine/Radiopharmaceutic Revenue 2015-2026
2.1.2 Global Nuclear Medicine/Radiopharmaceutic Sales 2015-2026
2.2 Nuclear Medicine/Radiopharmaceutic Market Size by Region: 2020 Versus 2026
2.2.1 Global Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTIC COMPETITOR LANDSCAPE BY PLAYERS
3.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers
3.1.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers (2015-2020)
3.1.2 Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturers (2015-2020)
3.2 Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers
3.2.1 Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2015-2020)
3.2.2 Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Nuclear Medicine/Radiopharmaceutic Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Nuclear Medicine/Radiopharmaceutic Revenue in 2019
3.2.5 Global Nuclear Medicine/Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Nuclear Medicine/Radiopharmaceutic Price by Manufacturers
3.4 Nuclear Medicine/Radiopharmaceutic Manufacturing Base Distribution, Product Types
3.4.1 Nuclear Medicine/Radiopharmaceutic Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
3.4.3 Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size by Type (2015-2020)
4.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020)
4.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Type (2015-2020)
4.1.3 Nuclear Medicine/Radiopharmaceutic Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Type (2021-2026)
4.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2021-2026)
4.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Type (2021-2026)
4.2.3 Nuclear Medicine/Radiopharmaceutic Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Nuclear Medicine/Radiopharmaceutic Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Nuclear Medicine/Radiopharmaceutic Market Size by Application (2015-2020)
5.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020)
5.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Application (2015-2020)
5.1.3 Nuclear Medicine/Radiopharmaceutic Price by Application (2015-2020)
5.2 Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Application (2021-2026)
5.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2021-2026)
5.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Application (2021-2026)
5.2.3 Global Nuclear Medicine/Radiopharmaceutic Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Nuclear Medicine/Radiopharmaceutic by Country
6.1.1 North America Nuclear Medicine/Radiopharmaceutic Sales by Country
6.1.2 North America Nuclear Medicine/Radiopharmaceutic Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Type
6.3 North America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Application
7 EUROPE
7.1 Europe Nuclear Medicine/Radiopharmaceutic by Country
7.1.1 Europe Nuclear Medicine/Radiopharmaceutic Sales by Country
7.1.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Type
7.3 Europe Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic by Region
8.1.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Region
8.1.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Type
8.3 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Nuclear Medicine/Radiopharmaceutic by Country
9.1.1 Latin America Nuclear Medicine/Radiopharmaceutic Sales by Country
9.1.2 Latin America Nuclear Medicine/Radiopharmaceutic Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Type
9.3 Central & South America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic by Country
10.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Country
10.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Type
10.3 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 GE Healthcare
11.1.1 GE Healthcare Corporation Information
11.1.2 GE Healthcare Description, Business Overview and Total Revenue
11.1.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Products Offered
11.1.5 GE Healthcare Recent Development
11.2 Bracco Imaging
11.2.1 Bracco Imaging Corporation Information
11.2.2 Bracco Imaging Description, Business Overview and Total Revenue
11.2.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Products Offered
11.2.5 Bracco Imaging Recent Development
11.3 Mallinckrodt
11.3.1 Mallinckrodt Corporation Information
11.3.2 Mallinckrodt Description, Business Overview and Total Revenue
11.3.3 Mallinckrodt Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Products Offered
11.3.5 Mallinckrodt Recent Development
11.4 Lantheus Medical Imaging
11.4.1 Lantheus Medical Imaging Corporation Information
11.4.2 Lantheus Medical Imaging Description, Business Overview and Total Revenue
11.4.3 Lantheus Medical Imaging Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Products Offered
11.4.5 Lantheus Medical Imaging Recent Development
11.5 Bayer
11.5.1 Bayer Corporation Information
11.5.2 Bayer Description, Business Overview and Total Revenue
11.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bayer Nuclear Medicine/Radiopharmaceutic Products Offered
11.5.5 Bayer Recent Development
11.6 Jubilant Pharma
11.6.1 Jubilant Pharma Corporation Information
11.6.2 Jubilant Pharma Description, Business Overview and Total Revenue
11.6.3 Jubilant Pharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Products Offered
11.6.5 Jubilant Pharma Recent Development
11.7 Nordion
11.7.1 Nordion Corporation Information
11.7.2 Nordion Description, Business Overview and Total Revenue
11.7.3 Nordion Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Nordion Nuclear Medicine/Radiopharmaceutic Products Offered
11.7.5 Nordion Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Corporation Information
11.8.2 Eli Lilly Description, Business Overview and Total Revenue
11.8.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Eli Lilly Nuclear Medicine/Radiopharmaceutic Products Offered
11.8.5 Eli Lilly Recent Development
11.9 SIEMENS
11.9.1 SIEMENS Corporation Information
11.9.2 SIEMENS Description, Business Overview and Total Revenue
11.9.3 SIEMENS Sales, Revenue and Gross Margin (2015-2020)
11.9.4 SIEMENS Nuclear Medicine/Radiopharmaceutic Products Offered
11.9.5 SIEMENS Recent Development
11.10 China Isotope & Radiation
11.10.1 China Isotope & Radiation Corporation Information
11.10.2 China Isotope & Radiation Description, Business Overview and Total Revenue
11.10.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
11.10.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Products Offered
11.10.5 China Isotope & Radiation Recent Development
11.1 GE Healthcare
11.1.1 GE Healthcare Corporation Information
11.1.2 GE Healthcare Description, Business Overview and Total Revenue
11.1.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Products Offered
11.1.5 GE Healthcare Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Nuclear Medicine/Radiopharmaceutic Market Estimates and Projections by Region
12.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions 2021-2026
12.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Regions 2021-2026
12.2 North America Nuclear Medicine/Radiopharmaceutic Market Size Forecast (2021-2026)
12.2.1 North America: Nuclear Medicine/Radiopharmaceutic Sales Forecast (2021-2026)
12.2.2 North America: Nuclear Medicine/Radiopharmaceutic Revenue Forecast (2021-2026)
12.2.3 North America: Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Country (2021-2026)
12.3 Europe Nuclear Medicine/Radiopharmaceutic Market Size Forecast (2021-2026)
12.3.1 Europe: Nuclear Medicine/Radiopharmaceutic Sales Forecast (2021-2026)
12.3.2 Europe: Nuclear Medicine/Radiopharmaceutic Revenue Forecast (2021-2026)
12.3.3 Europe: Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Nuclear Medicine/Radiopharmaceutic Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Nuclear Medicine/Radiopharmaceutic Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Region (2021-2026)
12.5 Latin America Nuclear Medicine/Radiopharmaceutic Market Size Forecast (2021-2026)
12.5.1 Latin America: Nuclear Medicine/Radiopharmaceutic Sales Forecast (2021-2026)
12.5.2 Latin America: Nuclear Medicine/Radiopharmaceutic Revenue Forecast (2021-2026)
12.5.3 Latin America: Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Nuclear Medicine/Radiopharmaceutic Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Nuclear Medicine/Radiopharmaceutic Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Nuclear Medicine/Radiopharmaceutic Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Nuclear Medicine/Radiopharmaceutic Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Nuclear Medicine/Radiopharmaceutic Product Introduction
1.2 Market Segments
1.3 Key Nuclear Medicine/Radiopharmaceutic Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Type
1.4.2 Tc-99
1.4.3 I-123/131
1.4.4 In-111
1.4.5 Xe-133
1.4.6 Th-201
1.4.7 Ga-67
1.4.8 Other
1.5 Market by Application
1.5.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Application
1.5.2 Diagnostic
1.5.3 Therapeutic
1.6 Coronavirus Disease 2019 (Covid-19): Nuclear Medicine/Radiopharmaceutic Industry Impact
1.6.1 How the Covid-19 is Affecting the Nuclear Medicine/Radiopharmaceutic Industry
1.6.1.1 Nuclear Medicine/Radiopharmaceutic Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Nuclear Medicine/Radiopharmaceutic Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Nuclear Medicine/Radiopharmaceutic Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Estimates and Forecasts
2.1.1 Global Nuclear Medicine/Radiopharmaceutic Revenue 2015-2026
2.1.2 Global Nuclear Medicine/Radiopharmaceutic Sales 2015-2026
2.2 Nuclear Medicine/Radiopharmaceutic Market Size by Region: 2020 Versus 2026
2.2.1 Global Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTIC COMPETITOR LANDSCAPE BY PLAYERS
3.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers
3.1.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers (2015-2020)
3.1.2 Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturers (2015-2020)
3.2 Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers
3.2.1 Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2015-2020)
3.2.2 Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Nuclear Medicine/Radiopharmaceutic Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Nuclear Medicine/Radiopharmaceutic Revenue in 2019
3.2.5 Global Nuclear Medicine/Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Nuclear Medicine/Radiopharmaceutic Price by Manufacturers
3.4 Nuclear Medicine/Radiopharmaceutic Manufacturing Base Distribution, Product Types
3.4.1 Nuclear Medicine/Radiopharmaceutic Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
3.4.3 Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size by Type (2015-2020)
4.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020)
4.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Type (2015-2020)
4.1.3 Nuclear Medicine/Radiopharmaceutic Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Type (2021-2026)
4.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2021-2026)
4.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Type (2021-2026)
4.2.3 Nuclear Medicine/Radiopharmaceutic Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Nuclear Medicine/Radiopharmaceutic Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Nuclear Medicine/Radiopharmaceutic Market Size by Application (2015-2020)
5.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020)
5.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Application (2015-2020)
5.1.3 Nuclear Medicine/Radiopharmaceutic Price by Application (2015-2020)
5.2 Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Application (2021-2026)
5.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2021-2026)
5.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Application (2021-2026)
5.2.3 Global Nuclear Medicine/Radiopharmaceutic Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Nuclear Medicine/Radiopharmaceutic by Country
6.1.1 North America Nuclear Medicine/Radiopharmaceutic Sales by Country
6.1.2 North America Nuclear Medicine/Radiopharmaceutic Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Type
6.3 North America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Application
7 EUROPE
7.1 Europe Nuclear Medicine/Radiopharmaceutic by Country
7.1.1 Europe Nuclear Medicine/Radiopharmaceutic Sales by Country
7.1.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Type
7.3 Europe Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic by Region
8.1.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Region
8.1.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Type
8.3 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Nuclear Medicine/Radiopharmaceutic by Country
9.1.1 Latin America Nuclear Medicine/Radiopharmaceutic Sales by Country
9.1.2 Latin America Nuclear Medicine/Radiopharmaceutic Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Type
9.3 Central & South America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic by Country
10.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Country
10.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Type
10.3 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 GE Healthcare
11.1.1 GE Healthcare Corporation Information
11.1.2 GE Healthcare Description, Business Overview and Total Revenue
11.1.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Products Offered
11.1.5 GE Healthcare Recent Development
11.2 Bracco Imaging
11.2.1 Bracco Imaging Corporation Information
11.2.2 Bracco Imaging Description, Business Overview and Total Revenue
11.2.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Products Offered
11.2.5 Bracco Imaging Recent Development
11.3 Mallinckrodt
11.3.1 Mallinckrodt Corporation Information
11.3.2 Mallinckrodt Description, Business Overview and Total Revenue
11.3.3 Mallinckrodt Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Products Offered
11.3.5 Mallinckrodt Recent Development
11.4 Lantheus Medical Imaging
11.4.1 Lantheus Medical Imaging Corporation Information
11.4.2 Lantheus Medical Imaging Description, Business Overview and Total Revenue
11.4.3 Lantheus Medical Imaging Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Products Offered
11.4.5 Lantheus Medical Imaging Recent Development
11.5 Bayer
11.5.1 Bayer Corporation Information
11.5.2 Bayer Description, Business Overview and Total Revenue
11.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bayer Nuclear Medicine/Radiopharmaceutic Products Offered
11.5.5 Bayer Recent Development
11.6 Jubilant Pharma
11.6.1 Jubilant Pharma Corporation Information
11.6.2 Jubilant Pharma Description, Business Overview and Total Revenue
11.6.3 Jubilant Pharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Products Offered
11.6.5 Jubilant Pharma Recent Development
11.7 Nordion
11.7.1 Nordion Corporation Information
11.7.2 Nordion Description, Business Overview and Total Revenue
11.7.3 Nordion Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Nordion Nuclear Medicine/Radiopharmaceutic Products Offered
11.7.5 Nordion Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Corporation Information
11.8.2 Eli Lilly Description, Business Overview and Total Revenue
11.8.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Eli Lilly Nuclear Medicine/Radiopharmaceutic Products Offered
11.8.5 Eli Lilly Recent Development
11.9 SIEMENS
11.9.1 SIEMENS Corporation Information
11.9.2 SIEMENS Description, Business Overview and Total Revenue
11.9.3 SIEMENS Sales, Revenue and Gross Margin (2015-2020)
11.9.4 SIEMENS Nuclear Medicine/Radiopharmaceutic Products Offered
11.9.5 SIEMENS Recent Development
11.10 China Isotope & Radiation
11.10.1 China Isotope & Radiation Corporation Information
11.10.2 China Isotope & Radiation Description, Business Overview and Total Revenue
11.10.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
11.10.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Products Offered
11.10.5 China Isotope & Radiation Recent Development
11.1 GE Healthcare
11.1.1 GE Healthcare Corporation Information
11.1.2 GE Healthcare Description, Business Overview and Total Revenue
11.1.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Products Offered
11.1.5 GE Healthcare Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Nuclear Medicine/Radiopharmaceutic Market Estimates and Projections by Region
12.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions 2021-2026
12.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Regions 2021-2026
12.2 North America Nuclear Medicine/Radiopharmaceutic Market Size Forecast (2021-2026)
12.2.1 North America: Nuclear Medicine/Radiopharmaceutic Sales Forecast (2021-2026)
12.2.2 North America: Nuclear Medicine/Radiopharmaceutic Revenue Forecast (2021-2026)
12.2.3 North America: Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Country (2021-2026)
12.3 Europe Nuclear Medicine/Radiopharmaceutic Market Size Forecast (2021-2026)
12.3.1 Europe: Nuclear Medicine/Radiopharmaceutic Sales Forecast (2021-2026)
12.3.2 Europe: Nuclear Medicine/Radiopharmaceutic Revenue Forecast (2021-2026)
12.3.3 Europe: Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Nuclear Medicine/Radiopharmaceutic Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Nuclear Medicine/Radiopharmaceutic Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Region (2021-2026)
12.5 Latin America Nuclear Medicine/Radiopharmaceutic Market Size Forecast (2021-2026)
12.5.1 Latin America: Nuclear Medicine/Radiopharmaceutic Sales Forecast (2021-2026)
12.5.2 Latin America: Nuclear Medicine/Radiopharmaceutic Revenue Forecast (2021-2026)
12.5.3 Latin America: Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Nuclear Medicine/Radiopharmaceutic Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Nuclear Medicine/Radiopharmaceutic Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Nuclear Medicine/Radiopharmaceutic Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Nuclear Medicine/Radiopharmaceutic Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Nuclear Medicine/Radiopharmaceutic Market Segments
Table 2. Ranking of Global Top Nuclear Medicine/Radiopharmaceutic Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Tc-99
Table 5. Major Manufacturers of I-123/131
Table 6. Major Manufacturers of In-111
Table 7. Major Manufacturers of Xe-133
Table 8. Major Manufacturers of Th-201
Table 9. Major Manufacturers of Ga-67
Table 10. Major Manufacturers of Other
Table 11. COVID-19 Impact Global Market: (Four Nuclear Medicine/Radiopharmaceutic Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Nuclear Medicine/Radiopharmaceutic Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Nuclear Medicine/Radiopharmaceutic Players to Combat Covid-19 Impact
Table 16. Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Application 2020-2026 (K MT)
Table 17. Global Nuclear Medicine/Radiopharmaceutic Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 18. Global Nuclear Medicine/Radiopharmaceutic Sales by Regions 2015-2020 (K MT)
Table 19. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions (2015-2020)
Table 20. Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions 2015-2020 (US$ Million)
Table 21. Global Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers (2015-2020) (K MT)
Table 22. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturers (2015-2020)
Table 23. Global Nuclear Medicine/Radiopharmaceutic Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 24. Global Nuclear Medicine/Radiopharmaceutic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceutic as of 2019)
Table 25. Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2015-2020) (US$ Million)
Table 26. Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2015-2020)
Table 27. Key Manufacturers Nuclear Medicine/Radiopharmaceutic Price (2015-2020) (USD/MT)
Table 28. Nuclear Medicine/Radiopharmaceutic Manufacturers Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
Table 30. Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
Table 31. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 32. Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020) (K MT)
Table 33. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2015-2020)
Table 34. Global Nuclear Medicine/Radiopharmaceutic Revenue by Type (2015-2020) (US$ Million)
Table 35. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2015-2020)
Table 36. Nuclear Medicine/Radiopharmaceutic Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 37. Global Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020) (K MT)
Table 38. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2015-2020)
Table 39. North America Nuclear Medicine/Radiopharmaceutic Sales by Country (2015-2020) (K MT)
Table 40. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2015-2020)
Table 41. North America Nuclear Medicine/Radiopharmaceutic Revenue by Country (2015-2020) (US$ Million)
Table 42. North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2015-2020)
Table 43. North America Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020) (K MT)
Table 44. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 45. North America Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020) (K MT)
Table 46. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Table 47. Europe Nuclear Medicine/Radiopharmaceutic Sales by Country (2015-2020) (K MT)
Table 48. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2015-2020)
Table 49. Europe Nuclear Medicine/Radiopharmaceutic Revenue by Country (2015-2020) (US$ Million)
Table 50. Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2015-2020)
Table 51. Europe Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020) (K MT)
Table 52. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 53. Europe Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020) (K MT)
Table 54. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Table 55. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Region (2015-2020) (K MT)
Table 56. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2015-2020)
Table 57. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Region (2015-2020) (US$ Million)
Table 58. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2015-2020)
Table 59. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020) (K MT)
Table 60. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 61. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020) (K MT)
Table 62. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Table 63. Latin America Nuclear Medicine/Radiopharmaceutic Sales by Country (2015-2020) (K MT)
Table 64. Latin America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2015-2020)
Table 65. Latin Americaa Nuclear Medicine/Radiopharmaceutic Revenue by Country (2015-2020) (US$ Million)
Table 66. Latin America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2015-2020)
Table 67. Latin America Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020) (K MT)
Table 68. Latin America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 69. Latin America Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020) (K MT)
Table 70. Latin America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Table 71. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Country (2015-2020) (K MT)
Table 72. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2015-2020)
Table 75. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020) (K MT)
Table 76. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 77. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020) (K MT)
Table 78. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Table 79. GE Healthcare Corporation Information
Table 80. GE Healthcare Description and Major Businesses
Table 81. GE Healthcare Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. GE Healthcare Product
Table 83. GE Healthcare Recent Development
Table 84. Bracco Imaging Corporation Information
Table 85. Bracco Imaging Description and Major Businesses
Table 86. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Bracco Imaging Product
Table 88. Bracco Imaging Recent Development
Table 89. Mallinckrodt Corporation Information
Table 90. Mallinckrodt Description and Major Businesses
Table 91. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Mallinckrodt Product
Table 93. Mallinckrodt Recent Development
Table 94. Lantheus Medical Imaging Corporation Information
Table 95. Lantheus Medical Imaging Description and Major Businesses
Table 96. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Lantheus Medical Imaging Product
Table 98. Lantheus Medical Imaging Recent Development
Table 99. Bayer Corporation Information
Table 100. Bayer Description and Major Businesses
Table 101. Bayer Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Bayer Product
Table 103. Bayer Recent Development
Table 104. Jubilant Pharma Corporation Information
Table 105. Jubilant Pharma Description and Major Businesses
Table 106. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Jubilant Pharma Product
Table 108. Jubilant Pharma Recent Development
Table 109. Nordion Corporation Information
Table 110. Nordion Description and Major Businesses
Table 111. Nordion Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Nordion Product
Table 113. Nordion Recent Development
Table 114. Eli Lilly Corporation Information
Table 115. Eli Lilly Description and Major Businesses
Table 116. Eli Lilly Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Eli Lilly Product
Table 118. Eli Lilly Recent Development
Table 119. SIEMENS Corporation Information
Table 120. SIEMENS Description and Major Businesses
Table 121. SIEMENS Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. SIEMENS Product
Table 123. SIEMENS Recent Development
Table 124. China Isotope & Radiation Corporation Information
Table 125. China Isotope & Radiation Description and Major Businesses
Table 126. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. China Isotope & Radiation Product
Table 128. China Isotope & Radiation Recent Development
Table 129. Yantai Dongcheng Biochemicals Corporation Information
Table 130. Yantai Dongcheng Biochemicals Description and Major Businesses
Table 131. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Yantai Dongcheng Biochemicals Product
Table 133. Yantai Dongcheng Biochemicals Recent Development
Table 134. Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions (2021-2026) (K MT)
Table 135. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Regions (2021-2026)
Table 136. Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 137. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Regions (2021-2026)
Table 138. North America: Nuclear Medicine/Radiopharmaceutic Sales Forecast by Country (2021-2026) (K MT)
Table 139. North America: Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Europe: Nuclear Medicine/Radiopharmaceutic Sales Forecast by Country (2021-2026) (K MT)
Table 141. Europe: Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Asia Pacific: Nuclear Medicine/Radiopharmaceutic Sales Forecast by Region (2021-2026) (K MT)
Table 143. Asia Pacific: Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Latin America: Nuclear Medicine/Radiopharmaceutic Sales Forecast by Country (2021-2026) (K MT)
Table 145. Latin America: Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Middle East and Africa: Nuclear Medicine/Radiopharmaceutic Sales Forecast by Country (2021-2026) (K MT)
Table 147. Middle East and Africa: Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Market Risks
Table 151. Main Points Interviewed from Key Nuclear Medicine/Radiopharmaceutic Players
Table 152. Nuclear Medicine/Radiopharmaceutic Customers List
Table 153. Nuclear Medicine/Radiopharmaceutic Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
Table 1. Nuclear Medicine/Radiopharmaceutic Market Segments
Table 2. Ranking of Global Top Nuclear Medicine/Radiopharmaceutic Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Tc-99
Table 5. Major Manufacturers of I-123/131
Table 6. Major Manufacturers of In-111
Table 7. Major Manufacturers of Xe-133
Table 8. Major Manufacturers of Th-201
Table 9. Major Manufacturers of Ga-67
Table 10. Major Manufacturers of Other
Table 11. COVID-19 Impact Global Market: (Four Nuclear Medicine/Radiopharmaceutic Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Nuclear Medicine/Radiopharmaceutic Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Nuclear Medicine/Radiopharmaceutic Players to Combat Covid-19 Impact
Table 16. Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Application 2020-2026 (K MT)
Table 17. Global Nuclear Medicine/Radiopharmaceutic Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 18. Global Nuclear Medicine/Radiopharmaceutic Sales by Regions 2015-2020 (K MT)
Table 19. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions (2015-2020)
Table 20. Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions 2015-2020 (US$ Million)
Table 21. Global Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers (2015-2020) (K MT)
Table 22. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturers (2015-2020)
Table 23. Global Nuclear Medicine/Radiopharmaceutic Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 24. Global Nuclear Medicine/Radiopharmaceutic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceutic as of 2019)
Table 25. Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2015-2020) (US$ Million)
Table 26. Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2015-2020)
Table 27. Key Manufacturers Nuclear Medicine/Radiopharmaceutic Price (2015-2020) (USD/MT)
Table 28. Nuclear Medicine/Radiopharmaceutic Manufacturers Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
Table 30. Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
Table 31. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 32. Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020) (K MT)
Table 33. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2015-2020)
Table 34. Global Nuclear Medicine/Radiopharmaceutic Revenue by Type (2015-2020) (US$ Million)
Table 35. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2015-2020)
Table 36. Nuclear Medicine/Radiopharmaceutic Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 37. Global Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020) (K MT)
Table 38. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2015-2020)
Table 39. North America Nuclear Medicine/Radiopharmaceutic Sales by Country (2015-2020) (K MT)
Table 40. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2015-2020)
Table 41. North America Nuclear Medicine/Radiopharmaceutic Revenue by Country (2015-2020) (US$ Million)
Table 42. North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2015-2020)
Table 43. North America Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020) (K MT)
Table 44. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 45. North America Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020) (K MT)
Table 46. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Table 47. Europe Nuclear Medicine/Radiopharmaceutic Sales by Country (2015-2020) (K MT)
Table 48. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2015-2020)
Table 49. Europe Nuclear Medicine/Radiopharmaceutic Revenue by Country (2015-2020) (US$ Million)
Table 50. Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2015-2020)
Table 51. Europe Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020) (K MT)
Table 52. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 53. Europe Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020) (K MT)
Table 54. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Table 55. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Region (2015-2020) (K MT)
Table 56. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2015-2020)
Table 57. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Region (2015-2020) (US$ Million)
Table 58. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2015-2020)
Table 59. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020) (K MT)
Table 60. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 61. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020) (K MT)
Table 62. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Table 63. Latin America Nuclear Medicine/Radiopharmaceutic Sales by Country (2015-2020) (K MT)
Table 64. Latin America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2015-2020)
Table 65. Latin Americaa Nuclear Medicine/Radiopharmaceutic Revenue by Country (2015-2020) (US$ Million)
Table 66. Latin America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2015-2020)
Table 67. Latin America Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020) (K MT)
Table 68. Latin America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 69. Latin America Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020) (K MT)
Table 70. Latin America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Table 71. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Country (2015-2020) (K MT)
Table 72. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2015-2020)
Table 75. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020) (K MT)
Table 76. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Table 77. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020) (K MT)
Table 78. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Table 79. GE Healthcare Corporation Information
Table 80. GE Healthcare Description and Major Businesses
Table 81. GE Healthcare Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. GE Healthcare Product
Table 83. GE Healthcare Recent Development
Table 84. Bracco Imaging Corporation Information
Table 85. Bracco Imaging Description and Major Businesses
Table 86. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Bracco Imaging Product
Table 88. Bracco Imaging Recent Development
Table 89. Mallinckrodt Corporation Information
Table 90. Mallinckrodt Description and Major Businesses
Table 91. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Mallinckrodt Product
Table 93. Mallinckrodt Recent Development
Table 94. Lantheus Medical Imaging Corporation Information
Table 95. Lantheus Medical Imaging Description and Major Businesses
Table 96. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Lantheus Medical Imaging Product
Table 98. Lantheus Medical Imaging Recent Development
Table 99. Bayer Corporation Information
Table 100. Bayer Description and Major Businesses
Table 101. Bayer Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Bayer Product
Table 103. Bayer Recent Development
Table 104. Jubilant Pharma Corporation Information
Table 105. Jubilant Pharma Description and Major Businesses
Table 106. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Jubilant Pharma Product
Table 108. Jubilant Pharma Recent Development
Table 109. Nordion Corporation Information
Table 110. Nordion Description and Major Businesses
Table 111. Nordion Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Nordion Product
Table 113. Nordion Recent Development
Table 114. Eli Lilly Corporation Information
Table 115. Eli Lilly Description and Major Businesses
Table 116. Eli Lilly Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Eli Lilly Product
Table 118. Eli Lilly Recent Development
Table 119. SIEMENS Corporation Information
Table 120. SIEMENS Description and Major Businesses
Table 121. SIEMENS Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. SIEMENS Product
Table 123. SIEMENS Recent Development
Table 124. China Isotope & Radiation Corporation Information
Table 125. China Isotope & Radiation Description and Major Businesses
Table 126. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. China Isotope & Radiation Product
Table 128. China Isotope & Radiation Recent Development
Table 129. Yantai Dongcheng Biochemicals Corporation Information
Table 130. Yantai Dongcheng Biochemicals Description and Major Businesses
Table 131. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Yantai Dongcheng Biochemicals Product
Table 133. Yantai Dongcheng Biochemicals Recent Development
Table 134. Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions (2021-2026) (K MT)
Table 135. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Regions (2021-2026)
Table 136. Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 137. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Regions (2021-2026)
Table 138. North America: Nuclear Medicine/Radiopharmaceutic Sales Forecast by Country (2021-2026) (K MT)
Table 139. North America: Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Europe: Nuclear Medicine/Radiopharmaceutic Sales Forecast by Country (2021-2026) (K MT)
Table 141. Europe: Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Asia Pacific: Nuclear Medicine/Radiopharmaceutic Sales Forecast by Region (2021-2026) (K MT)
Table 143. Asia Pacific: Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Latin America: Nuclear Medicine/Radiopharmaceutic Sales Forecast by Country (2021-2026) (K MT)
Table 145. Latin America: Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Middle East and Africa: Nuclear Medicine/Radiopharmaceutic Sales Forecast by Country (2021-2026) (K MT)
Table 147. Middle East and Africa: Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Market Risks
Table 151. Main Points Interviewed from Key Nuclear Medicine/Radiopharmaceutic Players
Table 152. Nuclear Medicine/Radiopharmaceutic Customers List
Table 153. Nuclear Medicine/Radiopharmaceutic Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Nuclear Medicine/Radiopharmaceutic Product Picture
Figure 2. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2020 & 2026
Figure 3. Tc-99 Product Picture
Figure 4. I-123/131 Product Picture
Figure 5. In-111 Product Picture
Figure 6. Xe-133 Product Picture
Figure 7. Th-201 Product Picture
Figure 8. Ga-67 Product Picture
Figure 9. Other Product Picture
Figure 10. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2020 & 2026
Figure 11. Diagnostic
Figure 12. Therapeutic
Figure 13. Nuclear Medicine/Radiopharmaceutic Report Years Considered
Figure 14. Global Nuclear Medicine/Radiopharmaceutic Market Size 2015-2026 (US$ Million)
Figure 15. Global Nuclear Medicine/Radiopharmaceutic Sales 2015-2026 (K MT)
Figure 16. Global Nuclear Medicine/Radiopharmaceutic Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2015-2020)
Figure 18. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region in 2019
Figure 19. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2015-2020)
Figure 20. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region in 2019
Figure 21. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Nuclear Medicine/Radiopharmaceutic Revenue in 2019
Figure 23. Nuclear Medicine/Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Figure 25. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2019
Figure 26. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type (2015-2020)
Figure 27. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type in 2019
Figure 28. Global Nuclear Medicine/Radiopharmaceutic Market Share by Price Range (2015-2020)
Figure 29. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Figure 30. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2019
Figure 31. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application (2015-2020)
Figure 32. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application in 2019
Figure 33. North America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2015-2020 (K MT)
Figure 34. North America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2019
Figure 36. North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country in 2019
Figure 37. U.S. Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 38. U.S. Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 40. Canada Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2019
Figure 42. North America Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2019
Figure 43. Europe Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2015-2020 (K MT)
Figure 44. Europe Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2019
Figure 46. Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country in 2019
Figure 47. Germany Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 48. Germany Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 50. France Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 52. U.K. Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 54. Italy Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 56. Russia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2019
Figure 58. Europe Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2019
Figure 59. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2015-2020 (K MT)
Figure 60. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region in 2019
Figure 62. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region in 2019
Figure 63. China Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 64. China Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 66. Japan Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 68. South Korea Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 70. India Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 72. Australia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 74. Taiwan Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 76. Indonesia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 78. Thailand Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 80. Malaysia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 82. Philippines Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 84. Vietnam Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2019
Figure 86. Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2019
Figure 87. Latin America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2015-2020 (K MT)
Figure 88. Latin America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2019
Figure 90. Latin America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country in 2019
Figure 91. Mexico Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 92. Mexico Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 94. Brazil Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 96. Argentina Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2019
Figure 98. Latin America Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2019
Figure 99. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2015-2020 (K MT)
Figure 100. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country in 2019
Figure 103. Turkey Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 104. Turkey Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 106. Saudi Arabia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 108. U.A.E Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2019
Figure 110. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2019
Figure 111. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Bracco Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Lantheus Medical Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Jubilant Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Nordion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. SIEMENS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Yantai Dongcheng Biochemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. North America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. North America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Europe Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. Europe Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 127. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Latin America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 129. Latin America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 131. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Porter's Five Forces Analysis
Figure 133. Channels of Distribution
Figure 134. Distributors Profiles
Figure 135. Bottom-up and Top-down Approaches for This Report
Figure 136. Data Triangulation
Figure 137. Key Executives Interviewed
Figure 1. Nuclear Medicine/Radiopharmaceutic Product Picture
Figure 2. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2020 & 2026
Figure 3. Tc-99 Product Picture
Figure 4. I-123/131 Product Picture
Figure 5. In-111 Product Picture
Figure 6. Xe-133 Product Picture
Figure 7. Th-201 Product Picture
Figure 8. Ga-67 Product Picture
Figure 9. Other Product Picture
Figure 10. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2020 & 2026
Figure 11. Diagnostic
Figure 12. Therapeutic
Figure 13. Nuclear Medicine/Radiopharmaceutic Report Years Considered
Figure 14. Global Nuclear Medicine/Radiopharmaceutic Market Size 2015-2026 (US$ Million)
Figure 15. Global Nuclear Medicine/Radiopharmaceutic Sales 2015-2026 (K MT)
Figure 16. Global Nuclear Medicine/Radiopharmaceutic Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2015-2020)
Figure 18. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region in 2019
Figure 19. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2015-2020)
Figure 20. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region in 2019
Figure 21. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Nuclear Medicine/Radiopharmaceutic Revenue in 2019
Figure 23. Nuclear Medicine/Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2015-2020)
Figure 25. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2019
Figure 26. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type (2015-2020)
Figure 27. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type in 2019
Figure 28. Global Nuclear Medicine/Radiopharmaceutic Market Share by Price Range (2015-2020)
Figure 29. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
Figure 30. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2019
Figure 31. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application (2015-2020)
Figure 32. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application in 2019
Figure 33. North America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2015-2020 (K MT)
Figure 34. North America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2019
Figure 36. North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country in 2019
Figure 37. U.S. Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 38. U.S. Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 40. Canada Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2019
Figure 42. North America Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2019
Figure 43. Europe Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2015-2020 (K MT)
Figure 44. Europe Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2019
Figure 46. Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country in 2019
Figure 47. Germany Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 48. Germany Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 50. France Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 52. U.K. Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 54. Italy Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 56. Russia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2019
Figure 58. Europe Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2019
Figure 59. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2015-2020 (K MT)
Figure 60. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region in 2019
Figure 62. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region in 2019
Figure 63. China Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 64. China Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 66. Japan Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 68. South Korea Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 70. India Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 72. Australia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 74. Taiwan Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 76. Indonesia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 78. Thailand Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 80. Malaysia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 82. Philippines Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 84. Vietnam Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2019
Figure 86. Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2019
Figure 87. Latin America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2015-2020 (K MT)
Figure 88. Latin America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2019
Figure 90. Latin America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country in 2019
Figure 91. Mexico Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 92. Mexico Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 94. Brazil Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 96. Argentina Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2019
Figure 98. Latin America Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2019
Figure 99. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2015-2020 (K MT)
Figure 100. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country in 2019
Figure 103. Turkey Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 104. Turkey Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 106. Saudi Arabia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2015-2020) (K MT)
Figure 108. U.A.E Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2019
Figure 110. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2019
Figure 111. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Bracco Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Lantheus Medical Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Jubilant Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Nordion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. SIEMENS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Yantai Dongcheng Biochemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. North America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. North America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Europe Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. Europe Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 127. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Latin America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 129. Latin America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 131. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Porter's Five Forces Analysis
Figure 133. Channels of Distribution
Figure 134. Distributors Profiles
Figure 135. Bottom-up and Top-down Approaches for This Report
Figure 136. Data Triangulation
Figure 137. Key Executives Interviewed
